EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serum Insights: Leveraging the Power of miRNA Profiling as an Early Diagnostic Tool for Non-Small Cell Lung Cancer

Radoslaw Charkiewicz iD, Anetta Sulewska iD, Robert Mroz, Alicja Charkiewicz, Wojciech Naumnik, Marcin Kraska, Attila Gyenesei, Bence Galik iD, Sini Junttila, Borys Miskiewicz, Rafal Stec, Piotr Karabowicz und 3 weitere

Cancers · 10.10.2023 · 15 (20) · 4910

DOI: 10.3390/cancers15204910 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 10.10.2023. Verfasst von Radoslaw Charkiewicz und 14 weiteren Autor:innen. Beteiligte Einrichtung: Center of Experimental Medicine, Medical University of Bialystok, 15-369 Bialystok, Poland. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Centre for Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-small cell lung cancer is the predominant form of lung cancer and is associated with a poor prognosis. MiRNAs implicated in cancer initiation and progression can be easily detected in liquid biopsy samples and have the potential to serve as non-invasive biomarkers. In this study, we employed next-generation sequencing to globally profile miRNAs in serum samples from 71 early-stage NSCLC patients and 47 non-cancerous pulmonary condition patients. Preliminary analysis of differentially expressed miRNAs revealed 28 upregulated miRNAs in NSCLC compared to the control group. Functional enrichment analyses unveiled their involvement in NSCLC signaling pathways. Subsequently, we developed a gradient-boosting decision tree classifier based on 2588 miRNAs, which demonstrated high accuracy (0.837), sensitivity (0.806), and specificity (0.859) in effectively distinguishing NSCLC from non-cancerous individuals. Shapley Additive exPlanations analysis improved the model metrics by identifying the top 15 miRNAs with the strongest discriminatory value, yielding an AUC of 0.96 ± 0.04, accuracy of 0.896, sensitivity of 0.884, and specificity of 0.903. Our study establishes the potential utility of a non-invasive serum miRNA signature as a supportive tool for early detection of NSCLC while also shedding light on dysregulated miRNAs in NSCLC biology. For enhanced credibility and understanding, further validation in an independent cohort of patients is warranted.

Schlagwörter

Stichwörter der Autor:innen

Shapley Additive exPlanationsbiomarkersgradient-boosting decision tree classifierliquid biopsymiRNAnext-generation sequencingnon-small cell lung cancer

Autor:innen und Institutionen

  • Center of Experimental Medicine, Medical University of Bialystok, 15-369 Bialystok, Poland.
  • Department of Clinical Molecular Biology, Medical University of Bialystok, 15-269 Bialystok, Poland.
  • 2nd Department of Lung Diseases and Tuberculosis, Medical University of Bialystok, 15-540 Bialystok, Poland.
  • Department of Analysis and Bioanalysis of Medicines, Medical University of Bialystok, 15-089 Bialystok, Poland.
  • 1st Department of Lung Diseases and Tuberculosis, Medical University of Bialystok, 15-540 Bialystok, Poland.
  • Department of Medical Pathomorphology, Medical University of Bialystok, 15-269 Bialystok, Poland.

ORCID-Profile: Radoslaw Charkiewicz, Anetta Sulewska, Bence Galik, Magdalena Zawada, Wojciech Miltyk

Förderung

  • National Centre for Research and Development

Zitieren

APA

Charkiewicz, R., Sulewska, A., Mroz, R., Charkiewicz, A., Naumnik, W., Kraska, M., Gyenesei, A., Galik, B., Junttila, S., Miskiewicz, B., Stec, R., Karabowicz, P., Zawada, M., Miltyk, W., & Niklinski, J. (2023). Serum Insights: Leveraging the Power of miRNA Profiling as an Early Diagnostic Tool for Non-Small Cell Lung Cancer. Cancers, 15(20), 4910. https://doi.org/10.3390/cancers15204910

Vancouver

Charkiewicz R, Sulewska A, Mroz R, Charkiewicz A, Naumnik W, Kraska M, et al. Serum Insights: Leveraging the Power of miRNA Profiling as an Early Diagnostic Tool for Non-Small Cell Lung Cancer. Cancers. 2023;15(20):4910. doi:10.3390/cancers15204910

BibTeX
@article{Charkiewicz2023,
  author = {Charkiewicz, Radoslaw and Sulewska, Anetta and Mroz, Robert and Charkiewicz, Alicja and Naumnik, Wojciech and Kraska, Marcin and Gyenesei, Attila and Galik, Bence and Junttila, Sini and Miskiewicz, Borys and Stec, Rafal and Karabowicz, Piotr and Zawada, Magdalena and Miltyk, Wojciech and Niklinski, Jacek},
  title = {Serum Insights: Leveraging the Power of miRNA Profiling as an Early Diagnostic Tool for Non-Small Cell Lung Cancer},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {20},
  pages = {4910},
  doi = {10.3390/cancers15204910}
}
Kostenlos starten →